Clinic
Geisinger Medical Center
Geisinger Medical Center was paid $27.85M by Medicaid between Jan 2018 and Dec 2024, across 622 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 8.5% of everything it billed.
33Billing provider infoGEISINGER MEDICAL CENTER
DANVILLE, PA 17822
DANVILLE, PA 17822
33aNPI1235215427assigned 10/31/2006
33bProvider typeClinic/Center
28Total paid$27.85M
24GClaims1,078,940
24DCodes billed622
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#7 of 176
Median peer was paid$441K
This provider vs. median63×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,087 | $162K | |
| 2019 | 3,830 | $123K | |
| 2020 | 110,576 | $2.79M | |
| 2021 | 504,551 | $14.07M | |
| 2022 | 158,259 | $4.05M | |
| 2023 | 169,300 | $3.85M | |
| 2024incomplete | 129,337 | $2.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 8.5% | 28,583 | 26,780 | $2.36M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 8.1% | 10,336 | 10,060 | $2.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 14,682 | 14,009 | $1.67M |
| 87631 | 3.6% | 7,286 | 7,035 | $1.00M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.4% | 10,712 | 10,297 | $950K |
| G0378 | Hospital observation service, per hour | 3.3% | 1,191 | 828 | $913K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.0% | 12,440 | 11,973 | $826K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 2.9% | 568 | 538 | $821K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 9,133 | 8,535 | $725K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.4% | 11,125 | 9,416 | $655K |
| 80053 | Comprehensive metabolic panel | 2.3% | 65,851 | 60,699 | $650K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 29,809 | 29,001 | $618K |
610 more codes
| J9271 | Injection, pembrolizumab, 1 mg | 2.0% | 659 | $570K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.7% | 2,828 | $473K |
| 80061 | Lipid panel | 1.5% | 33,119 | $425K |
| 300 | Patient transfer system <300 | 1.4% | 6,229 | $398K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.4% | 3,307 | $393K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 2,982 | $360K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1.3% | 238 | $356K |
| 87481 | 1.2% | 5,013 | $339K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.2% | 3,746 | $329K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.1% | 5,709 | $319K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 67,262 | $317K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.1% | 8,858 | $311K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 5,860 | $302K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 22,469 | $301K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,544 | $255K |
| Q3014 | Telehealth originating site facility fee | <1% | 18,463 | $248K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,777 | $232K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 9,183 | $211K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 5,565 | $205K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 31,131 | $195K |
| 0100U | <1% | 483 | $195K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 233 | $188K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 190 | $185K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,321 | $176K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 744 | $161K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,413 | $160K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 505 | $130K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 19,273 | $129K |
| 87430 | <1% | 18,647 | $120K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 455 | $118K |
| 36415 | Collection of venous blood by venipuncture | <1% | 66,946 | $112K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15,264 | $111K |
| 64615 | <1% | 1,409 | $111K | |
| 82607 | <1% | 9,188 | $105K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,937 | $105K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,338 | $99K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 3,348 | $98K |
| 80050 | General health panel | <1% | 2,195 | $97K |
| X0621 | <1% | 501 | $97K | |
| X0616 | <1% | 547 | $97K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,512 | $96K |
| 86803 | <1% | 5,241 | $91K | |
| 0002A | <1% | 2,510 | $89K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,240 | $88K |
| 82728 | <1% | 8,096 | $84K | |
| 85027 | <1% | 14,829 | $83K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,170 | $77K |
| 84702 | <1% | 5,247 | $76K | |
| 0001A | <1% | 2,595 | $76K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 970 | $73K |
| 76770 | <1% | 1,228 | $73K | |
| 87506 | <1% | 513 | $72K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 345 | $66K |
| 83970 | <1% | 1,798 | $60K | |
| 83540 | <1% | 8,247 | $60K | |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | <1% | 741 | $58K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,028 | $57K |
| 77386 | <1% | 222 | $57K | |
| 94010 | <1% | 1,727 | $55K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,198 | $55K |
| 83655 | <1% | 4,960 | $54K | |
| X0592 | <1% | 1,518 | $53K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,180 | $53K |
| 87511 | <1% | 2,661 | $52K | |
| X0620 | <1% | 366 | $52K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,028 | $51K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,450 | $50K |
| 86003 | <1% | 542 | $50K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 418 | $49K |
| 92557 | <1% | 1,784 | $48K | |
| 82570 | <1% | 7,580 | $48K | |
| 84439 | <1% | 5,586 | $42K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,055 | $41K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,059 | $41K |
| 86480 | <1% | 645 | $41K | |
| 87150 | <1% | 942 | $41K | |
| 82043 | <1% | 5,798 | $41K | |
| 92579 | <1% | 636 | $40K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,912 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 309 | $38K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 243 | $37K |
| 93325 | <1% | 1,514 | $34K | |
| 83550 | <1% | 7,892 | $34K | |
| 86618 | <1% | 1,451 | $33K | |
| 76830 | Ultrasound, transvaginal | <1% | 582 | $32K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 733 | $30K |
| 92567 | <1% | 3,142 | $30K | |
| 87536 | <1% | 301 | $29K | |
| 88342 | <1% | 981 | $28K | |
| 36561 | <1% | 30 | $28K | |
| 86317 | <1% | 1,214 | $28K | |
| 72141 | <1% | 140 | $28K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 405 | $27K |
| 87340 | <1% | 2,398 | $27K | |
| 83735 | <1% | 4,815 | $26K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 119 | $26K |
| 84484 | <1% | 3,441 | $26K | |
| 93296 | <1% | 2,108 | $26K | |
| 82784 | <1% | 1,432 | $25K | |
| 82746 | <1% | 2,572 | $25K | |
| 93971 | <1% | 390 | $25K | |
| 80074 | <1% | 530 | $25K | |
| 84146 | <1% | 1,075 | $25K | |
| 83880 | <1% | 946 | $25K | |
| X0615 | <1% | 151 | $24K | |
| 87186 | <1% | 3,247 | $23K | |
| 74183 | <1% | 84 | $23K | |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | <1% | 1,140 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,203 | $23K |
| 29581 | <1% | 1,330 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,421 | $23K |
| 72100 | <1% | 1,168 | $22K | |
| 84403 | <1% | 872 | $22K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 20 | $22K |
| 76885 | <1% | 209 | $22K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 300 | $21K |
| 90686 | <1% | 2,688 | $21K | |
| 84153 | <1% | 934 | $20K | |
| 80076 | <1% | 2,640 | $20K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 366 | $19K |
| 78264 | <1% | 188 | $19K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 670 | $19K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 98 | $19K |
| 85610 | <1% | 7,197 | $19K | |
| 96415 | <1% | 565 | $18K | |
| 95910 | <1% | 318 | $17K | |
| 96417 | <1% | 321 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 372 | $17K |
| 71250 | <1% | 285 | $17K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 487 | $17K |
| 83525 | <1% | 1,509 | $16K | |
| 81003 | <1% | 6,652 | $16K | |
| 81001 | <1% | 6,939 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 642 | $16K |
| 88341 | <1% | 479 | $15K | |
| 86780 | <1% | 1,035 | $15K | |
| 83520 | <1% | 1,312 | $15K | |
| 93304 | <1% | 599 | $15K | |
| 87077 | <1% | 2,299 | $15K | |
| 86762 | <1% | 1,081 | $15K | |
| 83690 | <1% | 3,655 | $15K | |
| 86360 | <1% | 279 | $15K | |
| 0012A | <1% | 515 | $15K | |
| 86850 | <1% | 3,257 | $15K | |
| 70496 | <1% | 70 | $14K | |
| 87529 | <1% | 234 | $14K | |
| 0004A | <1% | 344 | $14K | |
| 83605 | <1% | 2,556 | $14K | |
| 43235 | <1% | 106 | $14K | |
| 70498 | <1% | 103 | $13K | |
| J0185 | Injection, aprepitant, 1 mg | <1% | 226 | $13K |
| 86140 | <1% | 4,983 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 175 | $13K |
| 86038 | <1% | 907 | $13K | |
| 97161 | <1% | 308 | $12K | |
| 83001 | <1% | 761 | $12K | |
| 93880 | <1% | 186 | $12K | |
| 87641 | <1% | 559 | $12K | |
| J0897 | Injection, denosumab, 1 mg | <1% | 68 | $12K |
| 86900 | <1% | 3,773 | $12K | |
| 85652 | <1% | 4,470 | $12K | |
| 97165 | <1% | 335 | $11K | |
| 70486 | <1% | 175 | $11K | |
| 90715 | <1% | 1,465 | $11K | |
| 86359 | <1% | 279 | $11K | |
| 95886 | <1% | 824 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,625 | $11K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 118 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 291 | $11K |
| 82248 | <1% | 1,966 | $11K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 3,632 | $11K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 916 | $11K |
| 84481 | <1% | 490 | $11K | |
| 86147 | <1% | 147 | $11K | |
| 86235 | <1% | 285 | $11K | |
| 82805 | <1% | 481 | $10K | |
| 85046 | <1% | 1,929 | $10K | |
| 84100 | <1% | 2,511 | $10K | |
| 96040 | <1% | 352 | $10K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 261 | $10K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,113 | $10K |
| 88312 | <1% | 278 | $10K | |
| 84270 | <1% | 384 | $9K | |
| 86592 | <1% | 2,345 | $9K | |
| 93970 | <1% | 91 | $9K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 36 | $9K |
| 82565 | <1% | 1,943 | $9K | |
| 74018 | <1% | 761 | $9K | |
| 93321 | <1% | 792 | $9K | |
| 86787 | <1% | 595 | $9K | |
| 87070 | <1% | 1,583 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 350 | $9K |
| 0071A | <1% | 208 | $9K | |
| 86901 | <1% | 3,758 | $9K | |
| 83002 | <1% | 546 | $9K | |
| 92610 | <1% | 244 | $8K | |
| C1769 | Guide wire | <1% | 481 | $8K |
| 93350 | <1% | 197 | $8K | |
| 87088 | <1% | 1,195 | $8K | |
| 73610 | <1% | 587 | $8K | |
| 87902 | <1% | 50 | $8K | |
| 84630 | <1% | 727 | $8K | |
| 82670 | <1% | 423 | $8K | |
| 64405 | <1% | 227 | $8K | |
| 88313 | <1% | 187 | $8K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 104 | $8K |
| 0072A | <1% | 186 | $8K | |
| 72156 | <1% | 54 | $8K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 24 | $8K |
| 95909 | <1% | 180 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 207 | $8K |
| 80326 | <1% | 480 | $8K | |
| 86160 | <1% | 289 | $8K | |
| 97162 | <1% | 232 | $7K | |
| 76536 | <1% | 149 | $7K | |
| 93922 | <1% | 420 | $7K | |
| 82105 | <1% | 418 | $7K | |
| 74240 | <1% | 149 | $7K | |
| 80081 | <1% | 91 | $7K | |
| 86039 | <1% | 536 | $7K | |
| 82950 | <1% | 1,087 | $7K | |
| 85379 | <1% | 771 | $7K | |
| 80354 | <1% | 194 | $7K | |
| 80346 | <1% | 403 | $7K | |
| 82785 | <1% | 436 | $7K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 33 | $7K |
| 80164 | <1% | 428 | $7K | |
| 83615 | <1% | 1,242 | $7K | |
| 87493 | <1% | 201 | $7K | |
| 31231 | <1% | 129 | $7K | |
| 73564 | <1% | 486 | $7K | |
| 0011A | <1% | 403 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 92 | $7K |
| 80069 | <1% | 920 | $7K | |
| 81025 | <1% | 2,124 | $7K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 111 | $7K |
| 36591 | <1% | 308 | $7K | |
| 86665 | <1% | 176 | $6K | |
| 86800 | <1% | 373 | $6K | |
| 84305 | <1% | 287 | $6K | |
| 93320 | <1% | 437 | $6K | |
| 77336 | <1% | 165 | $6K | |
| 73630 | <1% | 819 | $6K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 172 | $6K |
| 92587 | <1% | 195 | $6K | |
| 87040 | <1% | 447 | $6K | |
| 88185 | <1% | 138 | $6K | |
| 59899 | <1% | 62 | $6K | |
| 86704 | <1% | 442 | $6K | |
| 84460 | <1% | 975 | $6K | |
| 72040 | <1% | 420 | $6K | |
| 73502 | <1% | 352 | $5K | |
| 83721 | <1% | 518 | $5K | |
| 86431 | <1% | 743 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 359 | $5K |
| 36430 | <1% | 221 | $5K | |
| 95819 | <1% | 388 | $5K | |
| 75561 | <1% | 14 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 39 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,795 | $5K |
| 0064A | <1% | 126 | $5K | |
| 72082 | <1% | 144 | $5K | |
| 450 | Pov group 1 hd 301-450 lbs | <1% | 20 | $5K |
| 84590 | <1% | 504 | $5K | |
| 84156 | <1% | 1,473 | $5K | |
| 73030 | <1% | 450 | $5K | |
| 86334 | <1% | 220 | $5K | |
| 95816 | <1% | 390 | $5K | |
| 82533 | <1% | 492 | $5K | |
| 82627 | <1% | 252 | $5K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 154 | $5K |
| 80047 | <1% | 587 | $5K | |
| 86225 | <1% | 371 | $5K | |
| 80365 | <1% | 138 | $5K | |
| 91200 | <1% | 235 | $5K | |
| 49083 | <1% | 76 | $4K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 173 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 528 | $4K |
| 92133 | <1% | 501 | $4K | |
| 0003A | <1% | 102 | $4K | |
| 84165 | <1% | 382 | $4K | |
| 82024 | <1% | 115 | $4K | |
| 82550 | <1% | 767 | $4K | |
| 83921 | <1% | 273 | $4K | |
| 73130 | <1% | 564 | $4K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 379 | $4K |
| 84450 | <1% | 680 | $4K | |
| 82657 | <1% | 113 | $4K | |
| 86617 | <1% | 105 | $4K | |
| 94729 | <1% | 411 | $4K | |
| 76825 | <1% | 147 | $4K | |
| 73590 | <1% | 348 | $4K | |
| 82525 | <1% | 401 | $4K | |
| 82962 | <1% | 3,442 | $4K | |
| 96376 | <1% | 185 | $4K | |
| 73562 | <1% | 361 | $4K | |
| 78227 | <1% | 14 | $4K | |
| 92134 | <1% | 506 | $4K | |
| 94060 | <1% | 396 | $4K | |
| A4220 | Refill kit for implantable infusion pump | <1% | 515 | $4K |
| 84550 | <1% | 708 | $4K | |
| 96411 | <1% | 66 | $4K | |
| 85730 | <1% | 738 | $4K | |
| 85018 | <1% | 1,314 | $4K | |
| 85007 | <1% | 1,343 | $4K | |
| 76820 | <1% | 252 | $4K | |
| 94726 | <1% | 334 | $4K | |
| 86708 | <1% | 236 | $3K | |
| 77072 | <1% | 267 | $3K | |
| 84112 | <1% | 62 | $3K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 3,325 | $3K |
| 86200 | <1% | 263 | $3K | |
| 84425 | <1% | 539 | $3K | |
| 82977 | <1% | 512 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $3K |
| 73221 | <1% | 13 | $3K | |
| 87338 | <1% | 214 | $3K | |
| 88142 | <1% | 192 | $3K | |
| 74230 | <1% | 110 | $3K | |
| 93293 | <1% | 320 | $3K | |
| 74174 | <1% | 13 | $3K | |
| 80197 | <1% | 327 | $3K | |
| 70491 | <1% | 29 | $3K | |
| 76881 | <1% | 33 | $3K | |
| 80361 | <1% | 138 | $3K | |
| 83516 | <1% | 236 | $3K | |
| 73552 | <1% | 248 | $3K | |
| 81513 | <1% | 46 | $3K | |
| 88307 | <1% | 220 | $3K | |
| 84681 | <1% | 106 | $3K | |
| 97166 | <1% | 164 | $3K | |
| 76942 | <1% | 126 | $3K | |
| 86376 | <1% | 380 | $3K | |
| 97597 | <1% | 113 | $3K | |
| 73560 | <1% | 289 | $3K | |
| 80175 | <1% | 227 | $3K | |
| 87075 | <1% | 380 | $3K | |
| 80177 | <1% | 237 | $3K | |
| 82951 | <1% | 214 | $3K | |
| 73110 | <1% | 318 | $3K | |
| 94664 | <1% | 209 | $2K | |
| 95885 | <1% | 152 | $2K | |
| 76642 | <1% | 68 | $2K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 139 | $2K |
| 77334 | <1% | 43 | $2K | |
| 88304 | <1% | 376 | $2K | |
| 82947 | <1% | 606 | $2K | |
| 20610 | <1% | 137 | $2K | |
| 83498 | <1% | 111 | $2K | |
| 93246 | <1% | 85 | $2K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 206 | $2K |
| 87328 | <1% | 239 | $2K | |
| 82040 | <1% | 876 | $2K | |
| 93926 | <1% | 41 | $2K | |
| 72170 | <1% | 248 | $2K | |
| 88184 | <1% | 94 | $2K | |
| 82247 | <1% | 377 | $2K | |
| 20611 | <1% | 51 | $2K | |
| 88173 | <1% | 125 | $2K | |
| 83090 | <1% | 124 | $2K | |
| 86923 | <1% | 195 | $2K | |
| 86765 | <1% | 162 | $2K | |
| 82375 | <1% | 589 | $2K | |
| 72158 | <1% | 14 | $2K | |
| 86735 | <1% | 149 | $2K | |
| 84520 | <1% | 512 | $2K | |
| 87205 | <1% | 616 | $2K | |
| 82378 | <1% | 170 | $2K | |
| 92523 | <1% | 14 | $2K | |
| 92083 | <1% | 37 | $2K | |
| 76827 | <1% | 124 | $2K | |
| 43762 | <1% | 107 | $2K | |
| 86664 | <1% | 89 | $2K | |
| 82330 | <1% | 265 | $2K | |
| 82310 | <1% | 433 | $2K | |
| 97168 | <1% | 40 | $2K | |
| 80178 | <1% | 225 | $2K | |
| 76801 | <1% | 46 | $2K | |
| 83021 | <1% | 83 | $2K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 278 | $2K |
| 73080 | <1% | 175 | $2K | |
| 95700 | <1% | 13 | $2K | |
| 11720 | <1% | 204 | $1K | |
| 320 | <1% | 17 | $1K | |
| 36416 | <1% | 1,340 | $1K | |
| 90670 | <1% | 227 | $1K | |
| 95117 | <1% | 63 | $1K | |
| 86255 | <1% | 73 | $1K | |
| 87046 | <1% | 558 | $1K | |
| 74455 | <1% | 38 | $1K | |
| 11056 | <1% | 64 | $1K | |
| 86146 | <1% | 24 | $1K | |
| 84446 | <1% | 167 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,175 | $1K |
| 73090 | <1% | 174 | $1K | |
| 84478 | <1% | 168 | $1K | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 68 | $1K |
| 71271 | <1% | 13 | $1K | |
| 84145 | <1% | 92 | $1K | |
| 84132 | <1% | 344 | $1K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 31 | $1K |
| 84207 | <1% | 29 | $1K | |
| 77001 | <1% | 91 | $1K | |
| 49452 | <1% | 14 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 51 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 48 | $1K |
| 76882 | <1% | 123 | $1K | |
| 82103 | <1% | 66 | $980.07 | |
| 99152 | <1% | 247 | $922.78 | |
| 76377 | <1% | 26 | $907.72 | |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $903.43 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,211 | $871.92 |
| J2704 | Injection, propofol, 10 mg | <1% | 7,389 | $859.67 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,219 | $841.35 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 43 | $821.05 |
| 97167 | <1% | 15 | $820.39 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $816.16 |
| C1788 | Port, indwelling (implantable) | <1% | 29 | $798.16 |
| 10005 | <1% | 13 | $784.28 | |
| 83050 | <1% | 467 | $782.13 | |
| P9021 | Red blood cells, each unit | <1% | 20 | $771.66 |
| 89051 | <1% | 255 | $745.78 | |
| 84075 | <1% | 201 | $744.73 | |
| 84300 | <1% | 113 | $743.59 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,296 | $741.90 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,867 | $725.05 |
| 93017 | <1% | 39 | $719.60 | |
| 89343 | <1% | 112 | $717.80 | |
| 11721 | <1% | 73 | $710.90 | |
| 87102 | <1% | 115 | $710.74 | |
| 85520 | <1% | 126 | $704.35 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 250 | $701.85 |
| 76870 | <1% | 17 | $680.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,746 | $674.34 |
| 86777 | <1% | 49 | $658.47 | |
| 82140 | <1% | 154 | $653.08 | |
| 82553 | <1% | 122 | $652.36 | |
| 86769 | <1% | 61 | $649.28 | |
| 72070 | <1% | 37 | $645.35 | |
| 73060 | <1% | 71 | $624.95 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 262 | $624.57 |
| 46600 | <1% | 38 | $619.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,600 | $614.48 |
| C1729 | Catheter, drainage | <1% | 69 | $610.72 |
| 86696 | <1% | 29 | $608.38 | |
| 83883 | <1% | 41 | $597.24 | |
| 0296T | <1% | 13 | $593.73 | |
| 82077 | <1% | 70 | $570.70 | |
| 82952 | <1% | 182 | $564.54 | |
| 87206 | <1% | 246 | $558.26 | |
| 82088 | <1% | 25 | $554.32 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 43 | $528.25 |
| 95908 | <1% | 13 | $517.24 | |
| 51700 | <1% | 21 | $512.87 | |
| 0013A | <1% | 12 | $508.80 | |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 12 | $508.80 |
| 80325 | <1% | 35 | $503.90 | |
| 86695 | <1% | 28 | $497.04 | |
| 82668 | <1% | 41 | $495.64 | |
| 92611 | <1% | 14 | $489.65 | |
| 82157 | <1% | 21 | $481.50 | |
| 84432 | <1% | 17 | $465.12 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 13,835 | $462.95 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 8,673 | $458.17 |
| 80299 | <1% | 43 | $456.00 | |
| 83010 | <1% | 55 | $450.17 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,180 | $444.51 |
| 80321 | <1% | 36 | $442.89 | |
| 97803 | <1% | 12 | $441.29 | |
| 87181 | <1% | 47 | $430.76 | |
| 82465 | <1% | 70 | $428.33 | |
| 82390 | <1% | 44 | $423.85 | |
| 59025 | Fetal non-stress test | <1% | 99 | $409.91 |
| 87497 | <1% | 23 | $406.64 | |
| 82340 | <1% | 53 | $402.89 | |
| 73523 | <1% | 12 | $394.57 | |
| 84480 | <1% | 54 | $392.57 | |
| 86644 | <1% | 26 | $390.58 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12,782 | $387.01 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 17 | $376.26 |
| 86308 | <1% | 60 | $371.45 | |
| 85014 | <1% | 123 | $366.76 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,802 | $362.78 |
| 90723 | <1% | 80 | $340.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 2,427 | $332.85 |
| 90680 | <1% | 58 | $330.00 | |
| 73140 | <1% | 45 | $328.06 | |
| 85246 | <1% | 12 | $315.85 | |
| 76000 | <1% | 81 | $314.22 | |
| 72110 | <1% | 15 | $313.20 | |
| 0054A | <1% | 12 | $313.00 | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 13 | $312.18 |
| 84133 | <1% | 53 | $311.99 | |
| 70360 | <1% | 24 | $308.36 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 796 | $306.61 |
| 83993 | <1% | 13 | $301.69 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,493 | $298.56 |
| 96402 | <1% | 15 | $294.66 | |
| 84597 | <1% | 15 | $281.75 | |
| 3052F | <1% | 77 | $280.75 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 325 | $268.15 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,609 | $267.72 |
| 87147 | <1% | 93 | $253.94 | |
| 90647 | <1% | 51 | $250.00 | |
| 90633 | <1% | 14 | $244.70 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 496 | $242.75 |
| 84295 | <1% | 68 | $242.35 | |
| 96523 | <1% | 16 | $230.36 | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 43 | $218.41 |
| 84134 | <1% | 13 | $217.28 | |
| 84144 | <1% | 14 | $216.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,200 | $214.90 |
| 82435 | <1% | 64 | $209.99 | |
| 84155 | <1% | 72 | $200.53 | |
| 11719 | <1% | 13 | $196.44 | |
| 86304 | <1% | 12 | $193.17 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 613 | $181.95 |
| 87015 | <1% | 60 | $171.78 | |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | <1% | 32 | $166.10 |
| 12001 | <1% | 15 | $165.40 | |
| 10060 | <1% | 13 | $163.53 | |
| 82150 | <1% | 47 | $159.45 | |
| 80179 | <1% | 13 | $157.08 | |
| 76857 | <1% | 13 | $149.10 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,823 | $147.88 |
| 82374 | <1% | 46 | $146.23 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 14 | $139.15 |
| 83020 | <1% | 14 | $138.60 | |
| 88104 | <1% | 16 | $138.00 | |
| 51701 | <1% | 12 | $136.17 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | $130.15 |
| 70355 | <1% | 12 | $129.36 | |
| 86812 | <1% | 14 | $126.12 | |
| 84244 | <1% | 12 | $114.12 | |
| 76937 | <1% | 74 | $113.27 | |
| 73100 | <1% | 13 | $109.99 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 282 | $107.39 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 283 | $106.21 |
| 87116 | <1% | 15 | $105.89 | |
| 89342 | <1% | 33 | $100.45 | |
| 81015 | <1% | 34 | $95.55 | |
| 82397 | <1% | 12 | $93.17 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 777 | $92.72 |
| 86364 | <1% | 16 | $91.67 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 976 | $88.45 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,657 | $88.12 |
| 94618 | <1% | 27 | $87.60 | |
| 3044F | <1% | 92 | $80.00 | |
| J1815 | Injection, insulin, per 5 units | <1% | 1,374 | $79.96 |
| 88108 | <1% | 29 | $78.54 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 191 | $66.04 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,226 | $59.83 |
| 88311 | <1% | 42 | $56.54 | |
| 87184 | <1% | 12 | $55.23 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,421 | $54.14 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 633 | $52.93 |
| 82274 | <1% | 15 | $43.38 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 441 | $40.22 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 345 | $38.48 |
| J0461 | Injection, atropine sulfate, 0.01 mg | <1% | 19 | $20.35 |
| J9250 | Methotrexate sodium, 5 mg | <1% | 82 | $15.54 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 123 | $9.08 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 62 | $6.48 |
| S0028 | Injection, famotidine, 20 mg | <1% | 37 | $2.11 |
| J3490 | Unclassified drugs | <1% | 305 | $2.07 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 62 | $1.38 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 70 | $0.70 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 74 | $0.06 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 1,264 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 109 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 0% | 81 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 301 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 385 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 139 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 40 | $0.00 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 0% | 13 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 92 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 13 | $0.00 |
| J1750 | Injection, iron dextran, 50 mg | 0% | 19 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 38 | $0.00 |
| 90746 | 0% | 12 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 254 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 131 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 41 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 17 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 106 | $0.00 |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 0% | 19 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 13 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 16 | $0.00 |
| 90662 | 0% | 29 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 124 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 785 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 158 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 251 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 284 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 84 | $0.00 |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | 0% | 83 | $0.00 |
| 90677 | 0% | 94 | $0.00 | |
| 90656 | 0% | 423 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 228 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 234 | $0.00 |
| J8501 | Aprepitant, oral, 5 mg | 0% | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 17 | $0.00 |
| J2805 | Injection, sincalide, 5 micrograms | 0% | 12 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 21 | $0.00 |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 0% | 29 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 0% | 22 | $0.00 |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | 0% | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 144 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (SYSTEM DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.